The use of in vivo antisense oligonucleotide technology for the investigation of brain GABA(A) receptors

Neurochemistry International

Volumn 31, Issue 3, 1997, Pages 437-446

  Karle, Jesper ^a   Witt, Michael Robin ^a   Nielsen, Mogens ^a  

^a Sct Hans Hospital   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANTISENSE OLIGONUCLEOTIDE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CHLORIDE CHANNEL; CHLORIDE ION; FLUNITRAZEPAM; MUSCIMOL; NEUROSTEROID; NEUROTRANSMITTER RECEPTOR; RADIOLIGAND;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN; BRAIN REGION; CELL LOSS; CONTINUOUS INFUSION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LATERAL BRAIN VENTRICLE; LIGAND BINDING; MALE; MEMBRANE BINDING; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; RAT; RECEPTOR AFFINITY;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CEREBRAL VENTRICLES; CORPUS STRIATUM; HIPPOCAMPUS; INFUSIONS, PARENTERAL; MALE; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, WISTAR; RECEPTORS, GABA-A;

ANIMALIA;

EID: 0030764468     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00113-1     Document Type: Article

References (33)

1. A receptor α subunits in cultured visual cortex slices reduces amplitude of evoked inhibitory postsynaptic currents. Neurosci. Lett. 191, 111-115,
2. Brussaard, A. B., Yang, X., Doyle, J. P., Buck, S. and Role, L. W. (1994) Developmental regulation of multiple nicotinic AChR channel subtypes in embryonic chick habenula neurons: contributions of both the α2 and α4 subunit genes. Pflügers Arch, Eur. J. Physiol. 429, 27-43.
3. Chiasson, B. J., Armstrong, J. N., Hooper, M, L., Murphy, P. R. and Robertson, H. A. (1994) The application of antisense oligonucleotide technology to the brain: some pitfalls. Cell. Mol. Neurobiol. 14, 507-521.
4. Chiasson, B. J., Hooper, M. L., Murphy, P. R. and Robertson, H. A. (1992) Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain. Eur. J. Pharmacol. Mol. Pharmacol. 227, 451-453.
5. Crooke, S. T. (1993) Progress toward oligonucleotide therapeutics: pharmacodynamic properties. FASEB J. 7, 533-539.
6. A receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359, 154-194.
7. GCG (1994) Program Manual for the Wisconsin Package. Genetics Computer Group, Madison, Wisconsin.
8. Green, W. N. and Millar, N. S. (1995) Ion-channel assembly. Trends Neurosci. 18, 280-287.
9. 2 subunit gene of -γ-aminobutyric acid type A receptors. Proc. Natl. Acad. Sci. U.S.A. 92, 7749-7753.
10. A receptor γ2 subunit subtype. Eur. J. Pharmacol. Mol. Pharmacol. 291, 439-441.
11. A receptor γ2 subunit induces loss of neurones in rat hippocampus. Neurosci. Lett. 202, 97-100.
12. Listerud, M., Brussaard, A. B., Devay, P., Colman, D. R. and Role, L. W. (1991) Functional contribution of neuronal AChR subunits revealed by antisense oligonucleotides. Science 254, 1518-1521.
13. A Receptor Channels. In Annual Reviews of Neuroscience, Vol. 17, pp. 569-602. Annual Reviews Inc.
14. McCabe, R. T., Olsen, R. W., Yezuita, J. P. and Wamsley, J. K. (1988) Osmotic shock: a method to eliminate endogenous γ-aminobutyric acid and account for the influence on benzodiazepine binding affinity in autoradiographic studies. J. Pharmacol. Exp. Ther. 245, 342 349.
15. 67 mRNAs modulate reproductive behavior in the female rat. Brain Res. 636, 209-220.
16. Nielsen, M. and Braestrup, C. (1988) The apparent target size of rat benzodiazepine receptor, acetylcholinesterase, and pyruvate kinase is highly influenced by experimental conditions. J. Biol. Chem. 263, 11900-11906.
17. Pilowsky, P. M., Suzuki, S. and Minson, J. B. (1994) Antisense oligonucleotides: a new tool in neuroscience. Clin. Exp. Pharmacol. Physiol. 21, 935-944.
18. A receptor subunit for benzodiazepine pharmacology. Nature 338, 582-585.
19. A receptor shows a ligand-gated receptor super-family. Nature 328, 221-227.
20. A receptor subunits exist in distinct neuronal subpopulations. Neuron 3, 327-337.
21. A receptor subtypes. Pharmacol. Rev. 47, 181-234.
22. A receptors on channel function. Neuron 5, 703-711.
23. A receptors are differentially sensitive to zinc: dependence on subunit composition. Br. J. Pharmacol. 103, 1837-1839.
24. Stein, C. A: and Cheng, Y.-C. (1993) Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 261, 1004-1012.
25. A receptors. Biochem. J. 610, 1-9.
26. Szklarczyk, A. and Kaczmarek, L. (1995) Antisense oligodeoxyribonucleotides: stability and distribution after intracerebral injection into rat brain. J. Neurosci. Methods 60, 181-187.
27. Thompson, S. M. (1993) Consequence of epileptic activity in vitro. Brain Pathol. 3, 413-419.
28. Wahlestedt, C. (1994) Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol. Sci. 15, 42-46.
29. Wahlestedt, C., Golanov, E., Yamamoto, S., Yee, F., Ericson, H., Yoo, H., Inturrisi, C. E. and Reis, D. J. (1993) Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature 363, 260-263.
30. Weiss, B., Zhou, L.-W., Zhang, S.-P. and Qin, Z.-H. (1993) Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA. Neuroscience 55, 607-612.
31. Whitesell, L., Geselowitz, D., Chavany, C., Fahmy, B., Walbridge, S., Alger, J. R. and Neckers, L. M. (1993) Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 90, 4665-4669.
32. Yaida, Y. and Nowak, T. S., Jr. (1995) Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization. Regul, Pept. 59, 193-199.
33. 2 receptors: behavioral correlates. Neurosci. Lett. 161, 223-226.